8-KRegulation FD

Guardant Health, Inc. 8-K Report, Regulation FD Disclosure (Sep 24, 2025)

Filed September 24, 2025For Securities:GH

Summary

Guardant Health, Inc. (GH) announced an upcoming Investor Day scheduled for September 24, 2025. This event will provide an opportunity for investors to hear directly from co-CEOs Helmy Eltoukhy and AmirAli Talasaz, along with other members of the executive management team. The presentations are expected to focus on the company's operational performance, strategic priorities, and updated financial outlook. This Investor Day presents a crucial opportunity for stakeholders to gain deeper insights into Guardant Health's current business trajectory and future plans. Investors should pay close attention to any new strategic initiatives, market expansion updates, and revisions to financial projections that may be shared during the event, as these could significantly impact the company's valuation and stock performance.

Key Highlights

  • 1Guardant Health to host an Investor Day on September 24, 2025.
  • 2Event will feature presentations from co-CEOs Helmy Eltoukhy and AmirAli Talasaz.
  • 3Executive management team will discuss company operations and strategic priorities.
  • 4An update to the company's financial outlook is expected.
  • 5A live and archived webcast will be available on the company's investor relations website.
  • 6Information furnished under Item 7.01 is not deemed 'filed' for purposes of Section 18 of the Exchange Act.

Frequently Asked Questions

The primary purpose of the Investor Day is for Guardant Health's management team to provide updates on the company's operations, highlight key strategic priorities, and share an updated financial outlook with investors.

The Investor Day will feature remarks from co-Chief Executive Officers Helmy Eltoukhy and AmirAli Talasaz, as well as other members of the executive management team.

Interested parties can access a live and archived webcast of the presentation through the 'Investors' section of Guardant Health's website at www.guardanthealth.com.

No, the information provided in this 8-K filing related to the Investor Day is furnished under Regulation FD and is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, nor is it automatically incorporated by reference into other SEC filings unless specifically stated.